$81.44
-5.66-6.5%
Last update: Nov 6, 8:05 AM
Globus Medical Inc
GMEDNYSE
Globus Medical (GMED) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Globus Medical (GMED) last issued guidance on November 5, 2026 for fiscal year 2026. The company guided earnings per share in the range of $4.95 - $5.05, compared to a consensus EPS estimate of $5. Globus Medical also guided revenue in the range of $3.09B - $3.09B for the period.
Compared to prior guidance, Globus Medical maintained its EPS outlook from a previous range of $4.95 - $5.05. On the revenue side, the company lowered its revenue forecast from a prior range of $3.18B - $3.22B.
Globus Medical has issued 28 guidance updates between November 8, 2022 and November 5, 2026. During this period, the company raised its outlook 14 times and lowered it 5 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.20 | $1.10 | $0.92 | $1.12 |
| Actual | $1.23 | $1.34 | $1.12 | $1.28 |
| Surprise | +2.50% | +21.8% | +21.7% | +14.3% |
| Revenue | ||||
| Estimate | $792.6M | $783.8M | $738.7M | $797.1M |
| Actual | $763.7M | $789.6M | $759.9M | $826.4M |
| Surprise | -3.64% | +0.74% | +2.86% | +3.68% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.34 | $1.23 | $1.40 | $1.33 |
| Revenue | ||||
| Consensus | $857.3M | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $1.23 | $1.20 | 2.50 % |
| Q2 | Aug 6, 2026 | $1.34 | $1.10 | 21.8 % |
| Q1 | May 7, 2026 | $1.12 | $0.92 | 21.7 % |
| Q4 | Feb 24, 2026 | $1.28 | $1.12 | 14.3 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $763.72M | $792.56M | -3.64 % |
| Q2 | Aug 6, 2026 | $789.61M | $783.78M | 0.74 % |
| Q1 | May 7, 2026 | $759.85M | $738.73M | 2.86 % |
| Q4 | Feb 24, 2026 | $826.42M | $797.11M | 3.68 % |
